Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07414784
PHASE1

A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

This Study of ABBV-295 subcutaneous injections will assess pharmacokinetics and adverse events in healthy adult women participants with overweight or obesity taking oral contraceptives.

Official title: A Phase 1 Drug-Drug Interaction Study of ABBV-295, Levonorgestrel, and Ethinyl Estradiol in Healthy Adult Female Subjects With Overweight or Obesity

Key Details

Gender

FEMALE

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-02-11

Completion Date

2026-07

Last Updated

2026-02-17

Healthy Volunteers

Yes

Interventions

DRUG

ABBV-295

Subcutaneous Injections

DRUG

Levonorgestrel/Ethinyl Estradiol

Oral Tablet

Locations (1)

ACPRU

Grayslake, Illinois, United States